Sternberg Flashcards

1
Q

Describe the clinical presentation of C1q nephropathy.

A

A rare disease of the young with poor outlook and unknown etiology. Presents with severe proteinemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the LM, IF, and EM findings in C1q nephropathy.

A

LM: Normal. Maybe some MH.

IF: Predominant mesangial C1q (in the absence of full-house SLE staining)

EM: Mesangial deposits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the clinical presentation of Collapsing Glomerulopathy.

A

Rapidly progressive nephrotic syndrome with poor outcome affecting mostly African Americans. HIV & Pamidronate associated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the LM findings of Collapsing Glomerulopathy.

A

Prominent swollen podocytes with large protein droplets. Tubulointerstitial edema & fibrosis with scalloping of microcysts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the IF and EM findings in Collapsing Glomerulopathy.

A

IF: Nonspecific.

EM: Endothelial tubuloreticular inclusions (only in HIV-associated form)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the clinical features of acute pyelonephritis.

A

Arises from ascending infection or hematogenous (“diffuse suppurative”) spread.

Presents with fever, pyuria, and CVA tenderness in usually women (worse with pregnancy & DM). E. Coli #1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the gross findings in acute pyelonephritis.

A

If ascending: Yellow medullary striping with abscess formation.

If hematogenous: Scattered, glomerulocentric cortical abscesses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the LM findings in acute pyelonephritis.

A

Neutrophils in the interstitium with tubular destruction. Follows a medullary/cortical distribution depending on etiology (ascending/hematogenous).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What proportion of TB cases manifest with renal disease? How does it present?

A

5%

Sterile pyuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the cause of Chinese Herb and Balkan Endemic nephropathies?

A

Aristolochic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the most common causes of end-stage kidney?

What role does determining the etiology play?

A

DM > HTN > GN > Chronic nephritis & ADPKD.

It is difficult/impossible but can be useful in determining utility of transplant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the gross appearance of the end-stage kidney.

A

Shrunken & atrophic cortex, granular surface and adherent capsule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the tubular patterns of atrophy in the end-stage kidney.

A

Classic: Atrophic tubules with wrinkled basement membranes and simplified epithelium

Endocrine type: Narrow lumina, pale cytoplasm (like adrenal cortex)

Thyroid type

Hypertrophic (compensatory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the vascular & glomerular LM findings in the end-stage kidney.

A

Arterial intimal obliteration, without lamellation. Worse with dialysis.

Can have capsular & JGA hyperplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the clinical features of acquired renal cystic disease?

A

Usually appears after several years on dialysis (pathogenesis unknown). Rarely can hemorrhage, increased RCC risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the gross and microscopic findings in acquired renal cystic disease?

A

Gross: 5+ cysts on imaging, involving at least 40% of the parenchymal volume

LM: Cysts with variable lining (flat, cuboidal, hyperplastic)

17
Q

What is the Banff scoring of AMR?

A

A. ATN-like

B. Capillary migration & thrombosis

C. Arterial necrosis

18
Q

What is the Banff scoring of ACR?

A

Ia (>25% of parenchyma, with moderate tubulitis)

Ib (>25% of parenchyma, with severe tubulitis)

IIa (mild-moderate intimal arteritis)

IIb (severe intimal arteritis, >25% of luminal area)

III (transmural arteritis / fibrinoid necrosis)

19
Q

What is the Banff breakdown of chronic rejection

A

Antibody mediated (C4d deposition with vascular disease and IFTA)

T-cell mediated (inflammatory cells in intima)

20
Q

What is the Banff scoring of IFTA?

A

I: Mild, <25% of volume

II: Moderate, 25-50% of volume

III: Severe, >50% of volume